Francesco Pavan

Dr. Francesco Pavan


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
NSNicola Siragusa
Nicola Siragusa
GBGloria Baldassari
Gloria Baldassari
Lorenzo FerrarioLorenzo Ferrario
Lorenzo Ferrario
LPLaura Passera
Laura Passera
BRBeatrice Rota
Beatrice Rota
Andrea CostantinoAndrea Costantino
Andrea Costantino
Irritable bowel syndrome (IBS) is a gut–brain axis chronic disorder, characterized by recurrent abdominal pain and altered bowel habits in the absence of organic pathology. Nutrition plays a central role in symptom management, yet no single dietary strategy has demonstrated universal effectiveness. This narrative review critically evaluates current nutritional approaches to IBS. The low-Fermentable Oligo-, Di-, Mono-saccharides and Polyols (FODMAP) diet is the most extensively studied and provides short-term symptom relief, but its long-term effects on microbiota diversity remain concerning. The Mediterranean diet, due to its anti-inflammatory and prebiotic properties, offers a sustainable, microbiota-friendly option; however, it has specific limitations in the context of IBS, particularly due to the adverse effects of certain FODMAP-rich foods. A gluten-free diet may benefit individuals with suspected non-celiac gluten sensitivity, although improvements are often attributed to fructan restriction and placebo and nocebo effects. Lactose-free diets are effective in patients with documented lactose intolerance, while a high-soluble-fiber diet is beneficial for constipation-predominant IBS. IgG-based elimination diets are emerging but remain controversial and require further validation. In this review, we present the 10 dietary commandments for IBS, pragmatic and easily retained recommendations. It advocates a personalized, flexible, and multidisciplinary management approach, avoiding rigidity and standardized protocols, with the aim of optimizing adherence, symptom mitigation, and health-related quality of life. Future research should aim to evaluate, in real-world clinical settings, the impact and applicability of the 10 dietary commandments for IBS in terms of symptom improvement and quality of life

18 October 2025 in Comprehensive Physiology
Verified
Journal Article
Open access
FPFrancesco Pavan
Francesco Pavan
SYSunil Singh Yadav
Sunil Singh Yadav
Andrea CostantinoAndrea Costantino
Andrea Costantino
ADAlessandra Dell'ERa
Alessandra Dell'ERa
MMMonic Mastroianni
Monic Mastroianni
MBMassimiliano Buoli
Massimiliano Buoli
Background: Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder affecting 5%–10% of the global population and is characterized by recurrent abdominal pain and dysregulation of bowel movements. Many patients do not benefit from full remission of symptoms by conventional treatments. Recently, yoga has demonstrated its potential benefits in various medical conditions including IBS, as a result of its effect on the gut‐brain axis. This systematic review evaluates the effectiveness of yoga for the management of IBS. Methods: We conducted a comprehensive literature search in PubMed and Scopus until March 2025 to identify studies on yogic posture, pranayama, and meditation in IBS. After excluding reviews, case reports, and studies not meeting age or design criteria, 10 studies were included. These were evaluated for methodological quality and classified as randomized controlled trials (RCTs) or non‐controlled trials. We analyzed outcomes related to gastrointestinal symptoms, quality of life, and psychological symptoms and examined the type of yoga administered. Results: Yoga interventions led to amelioration of gastrointestinal symptoms, decreased anxiety and depression, and enhanced quality of life compared to usual care or wait‐list controls. Of note, the studies that fixed the change in the IBS Symptom Severity Scale scores as the primary outcome showed a moderate‐large effect of yoga on the improvement of symptoms compared to controls (Cohen's d range: 0.37–3.60). Conclusion: These preliminary findings suggest that yoga could favorably influence both the physical and psychological aspects of IBS. However, high‐quality larger sample studies are needed to confirm the findings reported in the review.

28 March 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
FPFrancesco Pavan
Francesco Pavan
Andrea CostantinoAndrea Costantino
Andrea Costantino
GTGian Eugenio Tontini
Gian Eugenio Tontini
Luca ElliLuca Elli
Luca Elli
NSNicola Siragusa
Nicola Siragusa
MVMaurizio Vecchi
Maurizio Vecchi
Irritable bowel syndrome (IBS) is a gut–brain interaction disorder often associated with food-related triggers, yet the efficacy of common exclusion diets remains debated. Confocal laser endomicroscopy (CLE) offers real-time, high-resolution imaging of intestinal mucosal changes, allowing the visualization of food-induced barrier dysfunction. Early evidence indicates that a substantial subset of IBS patients exhibit acute mucosal reactions to specific foods, identified as fluorescein leakage and cell shedding on CLE, with over 70% showing symptom improvements after tailored exclusion diets. These findings suggest that localized immune responses and barrier defects may contribute to IBS symptoms beyond IgE-driven immunologic mechanisms. However, most CLE-based studies are small, unblinded, and heterogeneous, limiting definitive conclusions. Further research is needed to validate the diagnostic accuracy of CLE, refine protocols, and clarify how best to integrate CLE into personalized dietary management for difficult-to-treat IBS.

7 January 2026 in Antibodies
Verified
Journal Article
Open access
PDF file
GLGiovanni Lasagni
Giovanni Lasagni
LVLaura Vetrugno
Laura Vetrugno
CMChiara Maria Maggiore
Chiara Maria Maggiore
CGChiara Miho Grazia Galassetti
Chiara Miho Grazia Galassetti
GCGiulia Di Colo
Giulia Di Colo
LDLorenzo Dagna
Lorenzo Dagna
Background: Food allergy is a growing public health concern, and oral immunotherapy (OIT) has emerged as a promising approach to induce desensitization and potentially sustained unresponsiveness to allergenic foods. Changes in humoral immunity, particularly in allergen-specific immunoglobulin levels, play a central role in the immunological mechanisms underlying OIT. This review aims to summarize the current evidence on how OIT modulates allergen-specific immunoglobulin E (IgE), G (IgG) and A (IgA) responses in individuals with food allergy. Methods: We conducted a review of original research articles reporting longitudinal data on allergen-specific IgE, IgG, and/or IgA in patients undergoing OIT for common food allergens. Results: OIT was consistently associated with a transient increase in allergen-specific IgE levels during early phases, followed by a gradual decline. In contrast, Allergen-specific IgG4 levels showed a robust and sustained increase, correlating with desensitization and proposed to function as blocking antibodies. Several studies also reported an increase in allergen-specific IgA, particularly secretory IgA at mucosal sites, suggesting a potential role in enhancing mucosal tolerance and immune exclusion of allergens. Conclusions: Humoral immune responses during OIT are characterized by distinct and dynamic changes in immunoglobulin patterns. In particular, the rise in IgG4 and, in some cases, IgA suggests a role in promoting tolerance. Monitoring these biomarkers may offer insights into treatment efficacy and support individualized approaches to OIT.